Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European Stocks Subdued Ahead of Powell's Jackson Hole Speech

Published 08/27/2021, 03:56 AM
Updated 08/27/2021, 04:01 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets traded in a subdued fashion Friday, with investors wary of taking positions ahead of a highly anticipated speech by Federal Reserve Chairman Jerome Powell.

At 3:45 AM ET (0845 GMT), the DAX in Germany traded 0.1% higher, the CAC 40 in France was flat and the U.K.’s FTSE 100 climbed 0.1%.

The Jackson Hole symposium, the Fed's annual research conference for central bankers, is being held virtually this year, because of the Covid-19 virus. It has been the focus of the market all week as it has been often used by Fed policymakers in the past to provide guidance on future policy.

Powell is set to speak at 10 AM ET (1400 GMT), and his comments are expected to sketch a rough timeline for tapering the Fed's bond-buying program. This would mark the beginning of the end for the central bank’s unprecedented monetary support in the wake of the coronavirus outbreak.

Also prompting caution Friday was the deteriorating situation in Afghanistan after suicide bomb explosions outside the Kabul airport late Thursday killed numerous civilians and at least 13 U.S. soldiers.

Back in Europe, French consumer confidence edged lower in August, with worries about the highly contagious delta variant of the coronavirus and slowing economic momentum weighing. In Italy consumer confidence fell by less than expected, although business confidence turned down more sharply.

In corporate news, Just Eat Takeaway (F:T5W) stock fell 3.5% after New York approved legislation to license food-delivery apps and permanently cap commissions they can charge restaurants. The news will affect GrubHub (NYSE:GRUB), which JET is in the process of acquiring.

Morphosys (DE:MORG) stock added 3.1% after the European Commission approved the German biotech’s cancer drug.

Elsewhere, crude prices rose Friday, on track to post strong gains this week, with oil companies shutting down production in the Gulf of Mexico as Tropical Storm Ida approaches the region, threatening near-term supply disruption as it nears hurricane status.

Of interest later Friday will be the release of the Baker Hughes rig count data, while the Commodity Futures Trading Commission’s data on net positioning will also be studied for clues about the future direction of the market.

By 4 AM ET, U.S. crude futures traded 1.7% higher at $68.59 a barrel, heading for a weekly gain of more than 8%, while the Brent contract rose 1.3% to $71.10, on track for a rise of more than 9% this week.

Additionally, gold futures rose 0.4% to $1,801.45/oz, while EUR/USD traded 0.1% higher at 1.1755.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.